Literature DB >> 6133528

Benzodiazepines: a summary of pharmacokinetic properties.

D J Greenblatt, R I Shader, M Divoll, J S Harmatz.   

Abstract

1 The onset and duration of action of benzodiazepines after single oral doses depend largely on absorption rate and extent of distribution, respectively. 2 The rate and extent of accumulation during multiple dosage depend on elimination half-life and clearance. A framework is proposed for classification of benzodiazepines according to elimination half-life. 3 Long-acting benzodiazepines have half-life values usually exceeding 24 hours. Drugs in this category have long-acting pharmacologically active metabolites (often desmethyldiazepam), accumulate extensively during multiple dosage, and may have impaired clearance in the elderly and those with liver disease. 4 Intermediate and short-acting benzodiazepines have half-life values from 5-24 hours. Active metabolites are uncommon. Accumulation during multiple dosage is less extensive than with the long-acting group, and diminishes as the half-life becomes shorter. Age and liver disease have a small influence on metabolic clearance. 5 The half-life of ultrashort acting benzodiazepines is less than 5 hours. These drugs are essentially non-accumulating. 6 Pharmacokinetic classification may assist in understanding of differences among benzodiazepines, but does not explain all of their clinical actions.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6133528      PMCID: PMC1401650          DOI: 10.1111/j.1365-2125.1981.tb01833.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  26 in total

Review 1.  Clinical pharmacokinetics (second of two parts).

Authors:  D J Greenblatt; J Koch-Weser
Journal:  N Engl J Med       Date:  1975-11-06       Impact factor: 91.245

2.  Biopharmaceutical and clinical pharmacokinetic profile of bromazepam.

Authors:  S A Kaplan; M L Jack; R E Weinfeld; W Glover; L Weissman; S Cotler
Journal:  J Pharmacokinet Biopharm       Date:  1976-02

3.  Absorption and disposition of chlordiazepoxide in young and elderly male volunteers.

Authors:  R I Shader; D J Greenblatt; J S Harmatz; K Franke; J Koch-Weser
Journal:  J Clin Pharmacol       Date:  1977 Nov-Dec       Impact factor: 3.126

4.  Diazepam metabolism in normal man. II. Serum concentration and clinical effect after oral administration and cumulation.

Authors:  L Hillestad; T Hansen; H Melsom
Journal:  Clin Pharmacol Ther       Date:  1974-09       Impact factor: 6.875

5.  Human pharmacokinetics and bioavailability of temazepam administered in soft gelatin capsules.

Authors:  L M Fuccella; G Bolcioni; V Tamassia; L Ferrario; G Tognoni
Journal:  Eur J Clin Pharmacol       Date:  1977-12-16       Impact factor: 2.953

6.  Relative amnesic actions of diazepam, flunitrazepam and lorazepam in man.

Authors:  K A George; J W Dundee
Journal:  Br J Clin Pharmacol       Date:  1977-02       Impact factor: 4.335

Review 7.  Clinical pharmacokinetics of diazepam.

Authors:  M Mandelli; G Tognoni; S Garattini
Journal:  Clin Pharmacokinet       Date:  1978 Jan-Feb       Impact factor: 6.447

8.  Normal disposition of oxazepam in acute viral hepatitis and cirrhosis.

Authors:  H J Shull; G R Wilkinson; R Johnson; S Schenker
Journal:  Ann Intern Med       Date:  1976-04       Impact factor: 25.391

9.  Determination of medazepam (nobrium), diazepam(valium) and their major biotransformation products in blod and urine by electron capture s-liquid chromatography.

Authors:  J A De Silva; C V Puglisi
Journal:  Anal Chem       Date:  1970-12       Impact factor: 6.986

10.  Absorption rate, blood concentrations, and early response to oral chlordiazepoxide.

Authors:  D J Greenblatt; R I Shader; J S Harmatz; K Franke; J Koch-Weser
Journal:  Am J Psychiatry       Date:  1977-05       Impact factor: 18.112

View more
  40 in total

1.  Selective dissociations of sedation and amnesia following ingestion of diazepam.

Authors:  J B Rich; G G Brown
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

2.  Excretion of diazepam and its metabolites in human milk during withdrawal from combination high dose diazepam and oxazepam.

Authors:  L J Dusci; S M Good; R W Hall; K F Ilett
Journal:  Br J Clin Pharmacol       Date:  1990-01       Impact factor: 4.335

3.  Alcohol, drugs and driving: implications for evaluating driver impairment.

Authors:  Timothy Brown; Gary Milavetz; Daryl J Murry
Journal:  Ann Adv Automot Med       Date:  2013

Review 4.  Benzodiazepines for agitation in patients with delirium: selecting the right patient, right time, and right indication.

Authors:  David Hui
Journal:  Curr Opin Support Palliat Care       Date:  2018-12       Impact factor: 2.302

Review 5.  Pharmacological treatment of insomnia.

Authors:  M Maczaj
Journal:  Drugs       Date:  1993-01       Impact factor: 9.546

6.  Defeat engenders pentylenetetrazole-appropriate responding in rats: antagonism by midazolam.

Authors:  J A Vivian; E M Weerts; K A Miczek
Journal:  Psychopharmacology (Berl)       Date:  1994-12       Impact factor: 4.530

7.  Desmethyldiazepam kinetics after intravenous, intramuscular, and oral administration of clorazepate dipotassium.

Authors:  H R Ochs; E Steinhaus; A Locniskar; M Knüchel; D J Greenblatt
Journal:  Klin Wochenschr       Date:  1982-04-15

Review 8.  Benzodiazepine dependence. Avoidance and withdrawal.

Authors:  S Marriott; P Tyrer
Journal:  Drug Saf       Date:  1993-08       Impact factor: 5.606

9.  Oral self-administration of triazolam, diazepam and ethanol in the baboon: drug reinforcement and benzodiazepine physical dependence.

Authors:  N A Ator; R R Griffiths
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 10.  Abuse and dependence liability of benzodiazepine-type drugs: GABA(A) receptor modulation and beyond.

Authors:  Stephanie C Licata; James K Rowlett
Journal:  Pharmacol Biochem Behav       Date:  2008-01-12       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.